We have recently demonstrated that overexpression of PKC epsilon is oncogen
ic in colonic epithelial cells. To test whether PI3K might be an upstream e
ffector of PKC epsilon in cell transformation, we have overexpressed the p1
10 alpha PI3K subunit in non-transformed D/WT colonic epithelial cells. Tra
nsfectants displayed the major in vitro features of transformed cells. Inte
restingly, no transformation occurred when p110 alpha was co-transfected wi
th a dead-kinase PKC epsilon mutant. The p85 alpha subunit of PI3K, display
ing a dominant-negative-like effect, was then transfected in PKC epsilon -t
ransformed D/epsilon cells. The transformed profile of these cells was mark
edly reduced. To identify which by-products of PI3K might be involved in ce
ll transformation we have transfected the D/WT cell line with cDNAs encodin
g the PI3 kinases hVps34 and C2 beta. Overexpression of hVps34 did not caus
e cell transformation. Conversely, in vitro transformation was observed whe
n C2 beta was transfected into D/WT cells. These results indicate that phos
phatidylinositol-3 monophosphate does not seem to be involved in cell trans
formation, and that phosphatidylinositol-3,4 bisphosphate and phosphatidyli
nositol-3,4,5 trisphosphate are more likely involved in this process. Thus,
our data support the hypothesis of a linkage between PI3K and PKC epsilon,
and indicate that PI3K may act as a source of second messengers responsibl
e for oncogenic activation of PKC epsilon.